Titre : Hypersensibilité retardée

Hypersensibilité retardée : Questions médicales fréquentes

Termes MeSH sélectionnés :

Polymorphism, Single Nucleotide
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Hypersensibilité retardée : Questions médicales les plus fréquentes", "headline": "Hypersensibilité retardée : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Hypersensibilité retardée : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-04", "dateModified": "2025-03-30", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Hypersensibilité retardée" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Hypersensibilité", "url": "https://questionsmedicales.fr/mesh/D006967", "about": { "@type": "MedicalCondition", "name": "Hypersensibilité", "code": { "@type": "MedicalCode", "code": "D006967", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C20.543" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Eczéma de contact allergique", "alternateName": "Dermatitis, Allergic Contact", "url": "https://questionsmedicales.fr/mesh/D017449", "about": { "@type": "MedicalCondition", "name": "Eczéma de contact allergique", "code": { "@type": "MedicalCode", "code": "D017449", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C20.543.418.150" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Dermatite photoallergique", "alternateName": "Dermatitis, Photoallergic", "url": "https://questionsmedicales.fr/mesh/D017454", "about": { "@type": "MedicalCondition", "name": "Dermatite photoallergique", "code": { "@type": "MedicalCode", "code": "D017454", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C20.543.418.150.600" } } }, { "@type": "MedicalWebPage", "name": "Dermatite de contact au Rhus toxicodendron", "alternateName": "Dermatitis, Toxicodendron", "url": "https://questionsmedicales.fr/mesh/D011040", "about": { "@type": "MedicalCondition", "name": "Dermatite de contact au Rhus toxicodendron", "code": { "@type": "MedicalCode", "code": "D011040", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C20.543.418.150.700" } } } ] }, { "@type": "MedicalWebPage", "name": "Sarcoïdose", "alternateName": "Sarcoidosis", "url": "https://questionsmedicales.fr/mesh/D012507", "about": { "@type": "MedicalCondition", "name": "Sarcoïdose", "code": { "@type": "MedicalCode", "code": "D012507", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C20.543.418.575" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Sarcoïdose pulmonaire", "alternateName": "Sarcoidosis, Pulmonary", "url": "https://questionsmedicales.fr/mesh/D017565", "about": { "@type": "MedicalCondition", "name": "Sarcoïdose pulmonaire", "code": { "@type": "MedicalCode", "code": "D017565", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C20.543.418.575.725" } } }, { "@type": "MedicalWebPage", "name": "Uvéoparotidite", "alternateName": "Uveoparotid Fever", "url": "https://questionsmedicales.fr/mesh/D014608", "about": { "@type": "MedicalCondition", "name": "Uvéoparotidite", "code": { "@type": "MedicalCode", "code": "D014608", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C20.543.418.575.865" } } } ] } ], "about": { "@type": "MedicalCondition", "name": "Hypersensibilité retardée", "alternateName": "Hypersensitivity, Delayed", "code": { "@type": "MedicalCode", "code": "D006968", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Elizabeth J Phillips", "url": "https://questionsmedicales.fr/author/Elizabeth%20J%20Phillips", "affiliation": { "@type": "Organization", "name": "Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. Elizabeth.j.phillips@vumc.org." } }, { "@type": "Person", "name": "Shuen-Iu Hung", "url": "https://questionsmedicales.fr/author/Shuen-Iu%20Hung", "affiliation": { "@type": "Organization", "name": "Cancer Vaccine & Immune Cell Therapy Core Lab, Department of Medical Research, Chang Gung Memorial Hospital, Linkou Branch, No. 5, Fuxing St., Guishan Dist., Taoyuan 333, Taiwan; Department of Dermatology, Drug Hypersensitivity Clinical and Research Center, Chang Gung Memorial Hospital, Linkou Branch, No. 5, Fuxing St., Guishan Dist., Taoyuan 333, Taiwan; Department and Institute of Pharmacology, National Yang Ming Chiao Tung University, No.155, Sec.2, Linong Street, Taipei, 112 Taiwan. Electronic address: sihung@cgmh.org.tw." } }, { "@type": "Person", "name": "Andrew Gibson", "url": "https://questionsmedicales.fr/author/Andrew%20Gibson", "affiliation": { "@type": "Organization", "name": "Immunology and Infectious Diseases, Murdoch University, Murdoch, WA, Australia." } }, { "@type": "Person", "name": "Chuang-Wei Wang", "url": "https://questionsmedicales.fr/author/Chuang-Wei%20Wang", "affiliation": { "@type": "Organization", "name": "Cancer Vaccine & Immune Cell Therapy Core Lab, Department of Medical Research, Chang Gung Memorial Hospital, Linkou Branch, No. 5, Fuxing St., Guishan Dist., Taoyuan 333, Taiwan; Department of Dermatology, Drug Hypersensitivity Clinical and Research Center, Chang Gung Memorial Hospital, Linkou Branch, No. 5, Fuxing St., Guishan Dist., Taoyuan 333, Taiwan; Department of Dermatology, Xiamen Chang Gung Hospital, No. 123, Xiafei Road, Haicang District, Xiamen, China." } }, { "@type": "Person", "name": "Wen-Hung Chung", "url": "https://questionsmedicales.fr/author/Wen-Hung%20Chung", "affiliation": { "@type": "Organization", "name": "Cancer Vaccine & Immune Cell Therapy Core Lab, Department of Medical Research, Chang Gung Memorial Hospital, Linkou Branch, No. 5, Fuxing St., Guishan Dist., Taoyuan 333, Taiwan; Department of Dermatology, Drug Hypersensitivity Clinical and Research Center, Chang Gung Memorial Hospital, Linkou Branch, No. 5, Fuxing St., Guishan Dist., Taoyuan 333, Taiwan; Department of Dermatology, Xiamen Chang Gung Hospital, No. 123, Xiafei Road, Haicang District, Xiamen, China; Whole-Genome Research Core Laboratory of Human Diseases, Chang Gung Memorial Hospital, Keelung Branch, No. 222, Maijin Rd., Anle Dist., Keelung 204, Taiwan; College of Medicine, Chang Gung University, No.259, Wenhua 1st Rd., Guishan Dist., Taoyuan 333, Taiwan. Electronic address: chung1@cgmh.org.tw." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Novel single nucleotide polymorphisms in gestational diabetes mellitus.", "datePublished": "2022-11-12", "url": "https://questionsmedicales.fr/article/36375523", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.cca.2022.11.010" } }, { "@type": "ScholarlyArticle", "name": "Genotyping Single Nucleotide Polymorphisms in the Mitochondrial Genome by Pyrosequencing.", "datePublished": "2023-02-10", "url": "https://questionsmedicales.fr/article/36847373", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3791/64361" } }, { "@type": "ScholarlyArticle", "name": "Association between single nucleotide polymorphisms in exon 3 of the", "datePublished": "2022-11-15", "url": "https://questionsmedicales.fr/article/36380611", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1080/13816810.2022.2092757" } }, { "@type": "ScholarlyArticle", "name": "Effects of single-nucleotide polymorphism on the pharmacokinetics and pharmacodynamics of metformin.", "datePublished": "2022-09-05", "url": "https://questionsmedicales.fr/article/36065506", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1080/17512433.2022.2118714" } }, { "@type": "ScholarlyArticle", "name": "Potential role of FKBP5 single-nucleotide polymorphisms in functional seizures.", "datePublished": "2023-03-21", "url": "https://questionsmedicales.fr/article/36825897", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/epi4.12716" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Maladies du système immunitaire", "item": "https://questionsmedicales.fr/mesh/D007154" }, { "@type": "ListItem", "position": 3, "name": "Hypersensibilité", "item": "https://questionsmedicales.fr/mesh/D006967" }, { "@type": "ListItem", "position": 4, "name": "Hypersensibilité retardée", "item": "https://questionsmedicales.fr/mesh/D006968" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Hypersensibilité retardée - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Hypersensibilité retardée", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-05", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Hypersensibilité retardée", "description": "Comment diagnostiquer l'hypersensibilité retardée ?\nQuels tests sont utilisés pour le diagnostic ?\nQuels signes indiquent une hypersensibilité retardée ?\nPeut-on diagnostiquer par des analyses sanguines ?\nQuel rôle joue l'historique médical dans le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D006968?mesh_terms=Polymorphism,+Single+Nucleotide&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Hypersensibilité retardée", "description": "Quels sont les symptômes courants ?\nLes symptômes apparaissent-ils immédiatement ?\nY a-t-il des symptômes systémiques ?\nComment se manifeste une réaction cutanée ?\nLes symptômes varient-ils d'une personne à l'autre ?", "url": "https://questionsmedicales.fr/mesh/D006968?mesh_terms=Polymorphism,+Single+Nucleotide&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Hypersensibilité retardée", "description": "Comment prévenir l'hypersensibilité retardée ?\nLes tests d'allergie aident-ils à la prévention ?\nLes changements de mode de vie sont-ils nécessaires ?\nLes médicaments préventifs sont-ils disponibles ?\nComment gérer les expositions accidentelles ?", "url": "https://questionsmedicales.fr/mesh/D006968?mesh_terms=Polymorphism,+Single+Nucleotide&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Hypersensibilité retardée", "description": "Quel est le traitement principal de l'hypersensibilité retardée ?\nLes antihistaminiques sont-ils efficaces ?\nComment les corticostéroïdes aident-ils ?\nY a-t-il des traitements topiques recommandés ?\nLes traitements sont-ils différents pour les enfants ?", "url": "https://questionsmedicales.fr/mesh/D006968?mesh_terms=Polymorphism,+Single+Nucleotide&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Hypersensibilité retardée", "description": "Quelles complications peuvent survenir ?\nL'hypersensibilité retardée peut-elle entraîner des maladies chroniques ?\nY a-t-il un risque d'anaphylaxie ?\nComment les complications affectent-elles la qualité de vie ?\nLes complications nécessitent-elles une hospitalisation ?", "url": "https://questionsmedicales.fr/mesh/D006968?mesh_terms=Polymorphism,+Single+Nucleotide&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Hypersensibilité retardée", "description": "Quels sont les facteurs de risque principaux ?\nL'âge influence-t-il le risque d'hypersensibilité ?\nLes professions exposées sont-elles à risque ?\nLe stress peut-il aggraver l'hypersensibilité ?\nLes antécédents familiaux jouent-ils un rôle ?", "url": "https://questionsmedicales.fr/mesh/D006968?mesh_terms=Polymorphism,+Single+Nucleotide&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer l'hypersensibilité retardée ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'historique médical et des tests cutanés spécifiques." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour le diagnostic ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests de patch et les tests de stimulation lymphocytaire sont couramment utilisés." } }, { "@type": "Question", "name": "Quels signes indiquent une hypersensibilité retardée ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des éruptions cutanées, démangeaisons et rougeurs apparaissent après exposition à l'allergène." } }, { "@type": "Question", "name": "Peut-on diagnostiquer par des analyses sanguines ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Les analyses sanguines ne sont pas spécifiques, mais peuvent aider à évaluer l'inflammation." } }, { "@type": "Question", "name": "Quel rôle joue l'historique médical dans le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'historique médical aide à identifier les allergènes potentiels et les antécédents d'exposition." } }, { "@type": "Question", "name": "Quels sont les symptômes courants ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent éruptions cutanées, démangeaisons, et parfois fièvre." } }, { "@type": "Question", "name": "Les symptômes apparaissent-ils immédiatement ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Non, ils apparaissent généralement 24 à 72 heures après l'exposition à l'allergène." } }, { "@type": "Question", "name": "Y a-t-il des symptômes systémiques ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes systémiques comme la fièvre ou la fatigue peuvent survenir dans certains cas." } }, { "@type": "Question", "name": "Comment se manifeste une réaction cutanée ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "La réaction cutanée se manifeste par des rougeurs, des vésicules et un gonflement localisé." } }, { "@type": "Question", "name": "Les symptômes varient-ils d'une personne à l'autre ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'intensité et la nature des symptômes peuvent varier selon les individus." } }, { "@type": "Question", "name": "Comment prévenir l'hypersensibilité retardée ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Éviter l'exposition aux allergènes connus est la meilleure méthode de prévention." } }, { "@type": "Question", "name": "Les tests d'allergie aident-ils à la prévention ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les tests d'allergie peuvent identifier les allergènes à éviter pour prévenir les réactions." } }, { "@type": "Question", "name": "Les changements de mode de vie sont-ils nécessaires ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Des changements de mode de vie, comme éviter certains aliments ou produits, peuvent être nécessaires." } }, { "@type": "Question", "name": "Les médicaments préventifs sont-ils disponibles ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Des antihistaminiques peuvent être pris en prévention avant une exposition connue." } }, { "@type": "Question", "name": "Comment gérer les expositions accidentelles ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Avoir un plan d'action et des médicaments d'urgence peut aider à gérer les expositions accidentelles." } }, { "@type": "Question", "name": "Quel est le traitement principal de l'hypersensibilité retardée ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement principal consiste en l'évitement de l'allergène et l'utilisation de corticostéroïdes." } }, { "@type": "Question", "name": "Les antihistaminiques sont-ils efficaces ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Les antihistaminiques peuvent soulager les démangeaisons, mais ne traitent pas la cause." } }, { "@type": "Question", "name": "Comment les corticostéroïdes aident-ils ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Les corticostéroïdes réduisent l'inflammation et soulagent les symptômes cutanés." } }, { "@type": "Question", "name": "Y a-t-il des traitements topiques recommandés ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Des crèmes ou pommades corticostéroïdes peuvent être appliquées sur les zones affectées." } }, { "@type": "Question", "name": "Les traitements sont-ils différents pour les enfants ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les traitements peuvent être adaptés en fonction de l'âge et de la gravité des symptômes." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications comme des infections cutanées peuvent survenir si les lésions sont grattées." } }, { "@type": "Question", "name": "L'hypersensibilité retardée peut-elle entraîner des maladies chroniques ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des réactions répétées peuvent contribuer à des maladies cutanées chroniques." } }, { "@type": "Question", "name": "Y a-t-il un risque d'anaphylaxie ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "L'anaphylaxie est rare dans l'hypersensibilité retardée, mais des réactions sévères peuvent survenir." } }, { "@type": "Question", "name": "Comment les complications affectent-elles la qualité de vie ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Les complications peuvent entraîner des douleurs, des démangeaisons et une gêne sociale." } }, { "@type": "Question", "name": "Les complications nécessitent-elles une hospitalisation ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Dans certains cas graves, une hospitalisation peut être nécessaire pour un traitement intensif." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque principaux ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les antécédents d'allergies, l'exposition répétée et la génétique sont des facteurs de risque." } }, { "@type": "Question", "name": "L'âge influence-t-il le risque d'hypersensibilité ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les jeunes enfants et les personnes âgées peuvent être plus à risque." } }, { "@type": "Question", "name": "Les professions exposées sont-elles à risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Certaines professions, comme celles en contact avec des produits chimiques, présentent un risque accru." } }, { "@type": "Question", "name": "Le stress peut-il aggraver l'hypersensibilité ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress peut exacerber les symptômes et augmenter la sensibilité aux allergènes." } }, { "@type": "Question", "name": "Les antécédents familiaux jouent-ils un rôle ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un historique familial d'allergies peut augmenter le risque d'hypersensibilité retardée." } } ] } ] }

Sources (10000 au total)

Association between single nucleotide polymorphisms in exon 3 of the

The mutations in the αA-crystallin (CRYAA) gene may contribute to the development of age-related cataract (ARC). In this study, we searched for single nucleotide polymorphisms (SNP) in exons of CRYAA ... Peripheral venous blood was collected for the extraction of genomic DNA. Three exons of CRYAA were sequenced to detect SNPs. The frequency distributions of alleles and genotypes were compared between ... There were 618 patients with various subtypes of ARC (nuclear cataract [NC], cortical cataract [CC], posterior subcapsular cataract [PSC]). The control group comprised 236 patients. The incidence of e... The SNP rs76740365 G>A in exon 3 of the CRYAA gene is associated with greater susceptibility of ARC, particularly the PSC subtype. Individuals carrying the SNP rs76740365 G>A may be more likely to dev...

Effects of single-nucleotide polymorphism on the pharmacokinetics and pharmacodynamics of metformin.

Metformin has been recognized as the first-choice drug for type 2 diabetes mellitus (T2DM). The potency of metformin in the treatment of type 2 diabetes has always been in the spotlight and shown sign... Here, we reviewed the current knowledge about gene polymorphisms impacting metformin efficacy based on transporter and drug target proteins.... The reason for the difference in clinical drug potency of metformin can be attributed to the gene polymorphism of drug transporters and drug target proteins in the human body. Substantial evidence sho...

Potential role of FKBP5 single-nucleotide polymorphisms in functional seizures.

We investigated the associations between FKBP5 single-nucleotide polymorphisms (SNPs) and functional seizures (FS).... Seventy patients with FS, 140 with major depressive disorder (MDD), and 140 healthy controls were studied. Their DNAs were analyzed for the rs1360780 in the 3' region and rs9470080 in the 5' region of... Patients with FS and those with MDD had less GG and more AA genotypes in both rs9470080 and rs1360780 SNPs compared with those in healthy controls. Similar results were observed for allelic frequencie... Patients with FS and those with MDD had significantly different genotypes in both rs9470080 and rs1360780 SNPs compared with those in healthy controls. However, it seems that FKBP5 polymorphisms were ...

Associations of MALAT1 and its functional single nucleotide polymorphisms with cancer.

Systematic research on the associations between vital single nucleotide polymorphisms (SNPs) in MALAT1 and cancer risk was still lacking. Thus, we performed this study.... The literature searches were until April 1, 2022. The pooled association-analysis results were assessed by odds ratios (ORs) and the corresponding 95% confidence intervals (CIs) in three genetic model... Eighteen articles about four SNPs (rs619586, rs664589, rs1194338, and rs3200401) involving 11,843 cancer cases and 14,682 controls were collected. Rs619586, rs664589, and rs1194338 were associated wit... The functional SNPs in MALAT1 correlated with cancer risk. MALAT1 and its vital functional SNPs might be potential biomarkers for predicting the risk and prognosis of two types of cancer, especially C...

Analysis of single nucleotide polymorphisms of the metabotropic glutamate receptors in a transgender population.

Gender incongruence (GI) is characterized by a marked incongruence between an individual's experienced/expressed gender and the assigned sex at birth. It includes strong displeasure about his or her s... We analyzed 74 single nucleotide polymorphisms located at the metabotropic glutamate receptors (mGluR1, mGluR3, mGluR4, mGluR5, mGluR7 and mGluR8) in 94 transgender... After analysis of allele and genotypic frequencies, we found twenty-five polymorphisms with significant differences at level P ≤ 0.05, five at P ≤ 0.005 and two at P ≤ 0.0005. Furthermore, the only tw... We provide genetic evidence that the mGluR7, and therefore glutamatergic neurotransmission, may be involved in GI and GD....